Dominique Santos Rubenich

Ms. Dominique Santos Rubenich

Universidade Federal de Ciências da Saúde DE PORTO ALEGRE
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2021 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
Dominique Santos RubenichDominique Santos Rubenich
Dominique Santos Rubenich
NONatália Omizzollo
Natália Omizzollo
Mirosław J. SzczepańskiMirosław J. Szczepański
Mirosław J. Szczepański
TRTorsten E. Reichert
Torsten E. Reichert
TWTheresa L. Whiteside
Theresa L. Whiteside
EBElizandra Braganhol
Elizandra Braganhol

2 December 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Nils LudwigNils Ludwig
Nils Ludwig
Dominique Santos RubenichDominique Santos Rubenich
Dominique Santos Rubenich
LZLukasz Zareba
Lukasz Zareba
JSJacek Siewiera
Jacek Siewiera
JPJosquin Pieper
Josquin Pieper
Mirosław J. SzczepańskiMirosław J. Szczepański
Mirosław J. Szczepański
Extracellular vesicles (EVs) are produced and released by all cells and are present in all body fluids. They exist in a variety of sizes, however, small extracellular vesicles (sEVs), the EV subset with a size range from 30 to 150 nm, are of current interest. They are characterized by a distinct biogenesis and complex cargo composition, which reflects the cytosolic contents and cell-surface molecules of the parent cells. This cargo consists of proteins, nucleic acids, and lipids and is competent in inducing signaling cascades in recipient cells after surface interactions or in initiating the generation of a functional protein by delivering nucleic acids. Based on these characteristics, sEVs are now considered as important mediators of intercellular communication. One hallmark of sEVs is the promotion of angiogenesis. It was shown that sEVs interact with endothelial cells (ECs) and promote an angiogenic phenotype, ultimately leading to increased vascularization of solid tumors and disease progression. It was also shown that sEVs reprogram cells in the tumor microenvironment (TME) and act in a functionally cooperative fashion to promote angiogenesis by a paracrine mechanism involving the differential expression and secretion of angiogenic factors from other cell types. In this review, we will focus on the distinct functions of tumor-cell-derived sEVs (TEX) in promotion of angiogenesis and describe their potential as a therapeutic target for anti-angiogenic therapies. Also, we will focus on non-cancer stroma-cell-derived small extracellular vesicles and their potential role in stimulating a pro-angiogenic TME.

8 July 2024 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
Dominique Santos RubenichDominique Santos Rubenich
Dominique Santos Rubenich
JDJordana L. Domagalski
Jordana L. Domagalski
GGGabriela F. S. Gentil
Gabriela F. S. Gentil
JEJonas Eichberger
Jonas Eichberger
MFMathias Fiedler
Mathias Fiedler
DSDaniela Schulz
Daniela Schulz
Head and neck squamous cell carcinoma (HNSCC) is a global cancer burden with a 5‐year overall survival rate of around 50%, stagnant for decades. A tumour‐induced immunosuppressive microenvironment contributes to HNSCC progression, with the adenosine (ADO) pathway and an upregulated expression of inhibitory immune checkpoint regulators playing a key role in this context. The correlation between high neutrophil‐to‐lymphocyte ratio (NLR) with advanced tumour staging suggests involvement of neutrophils (NØ) in cancer progression. Interestingly, we associated a high NLR with an increased intracellular PD‐L1 localization in primary HNSCC samples, potentially mediating more aggressive tumour characteristics and therefore synergistically favouring tumour progression. Still, further research is needed to harness this knowledge for effective treatments and overcome resistance. Since it is hypothesized that the tumour microenvironment (TME) may be influenced by small extracellular vesicles (sEVs) secreted by tumours (TEX), this study aims to investigate the impact of HNSCC‐derived TEX on NØ and blockade of ADO receptors as a potential strategy to reverse the pro‐tumour phenotype of NØ. UMSCC47‐TEX exhibited CD73 enzymatic activity involved in ADO signalling, as well as the immune checkpoint inhibitor PD‐L1. Data revealed that TEX induce chemotaxis of NØ and the sustained interaction promotes a shift into a pro‐tumour phenotype, dependent on ADO receptors (P1R), increasing CD170high subpopulation, CD73 and PD‐L1 expression, followed by an immunosuppressive secretome. Blocking A3R reduced CD73 and PD‐L1 expression. Co‐culture experiments with HNSCC cells demonstrated that TEX‐modulated NØ increase the CD73/PD‐L1 axis, through Cyclin D‐CDK4/6 signalling. To support these findings, the CAM model with primary tumour was treated with NØ supernatant. Moreover, these NØ promoted an increase in migration, invasion, and reduced cell death. Targeting P1R on NØ, particularly A3R, exhibited potential therapeutic strategy to counteract immunosuppression in HNSCC. Understanding the TEX‐mediated crosstalk between tumours and NØ offers insights into immunomodulation for improving cancer therapies.

21 March 2023 in Immunology Letters
Verified
Journal Article
Closed access
NGNicolly Espindola Gelsleichter
Nicolly Espindola Gelsleichter
JAJuliana Hofstätter Azambuja
Juliana Hofstätter Azambuja
Dominique Santos RubenichDominique Santos Rubenich
Dominique Santos Rubenich
EBElizandra Braganhol
Elizandra Braganhol

12 November 2016 in Medical Mycology
Verified
Journal Article
Closed access
PDF file
AMAlexandre A. Monteiro
Alexandre A. Monteiro
Dominique Santos RubenichDominique Santos Rubenich
Dominique Santos Rubenich
MZMarilia R. Zandoná
Marilia R. Zandoná
APAlessandro C. Pasqualotto
Alessandro C. Pasqualotto
Invasive aspergillosis (IA) is associated with a high morbidity and mortality. Since Aspergillus species are usually not cultured in these patients, presumptive diagnosis of IA is more commonly based on galactomannan (GM) detection. Several factors are known to cause false-positive results in the GM test, but little is known on the influence of pre-analytical variables interfering on the test. Here we studied the influence of temperature and sample storage duration in GM results, using samples known to be negative and positive (spiked) for GM. We also evaluated the effect of hemolysis and hyperbilirubinemia on GM optical indexes. We found no influence of storage time (up to 96 h) and temperatures (refrigerated vs. RT) on GM results. However, bilirubin (P = .022) and haemoglobin (P = .003) content influenced GM readings in samples known for being GM positive and negative at baseline, respectively. We conclude that the Platelia GM test does not suffer major influence of pre-analytical variables such as storage conditions, and low levels of hemolysis and hyperbilirubinemia. Nonetheless, massive haemolysis seems to interfere with GM readings in GM-negative samples, and high levels of bilirubin can affect GM readings in samples that are positive for GM at baseline. These findings may facilitate logistics and the implementation of standard operational procedures in clinical laboratories.